Laos’ leading generic drug company

In the global pharmaceutical field, Laos Lucius Pharmaceuticals is emerging and becoming a highly watched presence in the industry. Its development not only adds luster to Laos’ pharmaceutical industry, but also brings hope to patients around the world.

Lucius Pharmaceuticals was established in 2020 and is headquartered in Vientiane, the capital of the Lao People’s Democratic Republic. Since its inception, Lucius Pharmaceuticals has set a great mission of “making effective and affordable medicines available to people in need around the world.” Driven by this mission, it continues to move forward and is committed to providing safe, efficient and reasonably priced medicines to patients around the world.

Laos Generic Drugs Lucius

In just a few years, Lucius Pharmaceuticals has achieved remarkable results. Its business scope has spread all over the world, and it has established solid partnerships with more than ten countries including China, Thailand, Singapore, Turkey, and Japan. Its factory covers an area of ​​about 25,000 square meters and has advanced modern production facilities and equipment, which provides hardware guarantees for the production of high-quality medicines. Its product line is rich and diverse, covering more than 200 types of generic drugs, including anti-tumor drugs, cardiovascular drugs, hematology drugs, diabetes drugs, dermatology drugs, men’s health drugs, anti-aging drugs, etc., meeting the medication needs of different patient groups.

In terms of drug quality control, Lucius Pharmaceuticals strictly abides by the requirements of the international Good Manufacturing Practice (GMP) for pharmaceutical production and has obtained the GMP qualification certification of the World Health Organization. From raw material procurement, production process to finished product inspection, every link is strictly controlled, with a complete quality traceability system to ensure that the quality of drugs is controllable and traceable, so that patients can use drugs with confidence.

Innovation is an important driving force for the development of Lucius Pharmaceuticals. The company invests a lot of profits in research and development every year, and has established close cooperative relations with well-known scientific research institutions at home and abroad. At present, it has a number of independent intellectual property rights, and its product line has also expanded from the original generic drugs to innovative drugs, biological preparations and other fields. For example, the anti-cancer drug Adagracibu tablets developed by Miratitheraps in the United States and launched in November 2022 has significant efficacy but high price, which many patients are deterred from. After continuous efforts and research, Lucius Pharmaceuticals has successfully developed a generic version of Adagelasib tablets, obtained the drug registration number of the Lao Food and Drug Administration and launched it to the global market. The price of this product is only one-tenth of the original drug, breaking the monopoly of the original manufacturer, bringing new hope to patients, and the effect is significant after patients use it. In the field of antiviral drugs, for the expensive genuine Wansaiwei in the treatment of cytomegalovirus (CMV), the Lao Lucius version of Wansaiwei has become the king of cost-effectiveness with a box of 450mg*60 tablets of about 1,000 yuan. Its production process strictly follows the international pharmaceutical production quality management standards to ensure that the efficacy is equivalent to the original drug. It has been officially approved by the Lao government and is a regular drug certified by the Lao Ministry of Health.

Lucius Pharmaceuticals’ global layout is also progressing steadily. It has established branches in Southeast Asia, Africa, South America and other regions, and its products are exported to dozens of countries and regions around the world. Its internationalization strategy not only brings broad development prospects to the company, but also enhances the international influence of Lao pharmaceutical industry.

As a rising star in the pharmaceutical field, Lucius Pharmaceuticals is contributing to the global health cause with its mission, strict quality control, continuous innovation and global layout. I believe that in the future, Lucius Pharmaceuticals will continue to uphold its original intention, develop and produce more high-quality and affordable drugs to benefit more patients around the world.